)
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Under the FTA, tariffs on automotive imports will come down by 50 per cent over 10 years (out of quota)
The UK-India Free Trade Agreement is expected to boost trade in pharmaceuticals and medical devices, though industry players remain cautious about the impact of country of origin rules
Fronx drives Maruti Suzuki's record FY25 exports with 69,000 units shipped globally, becoming the fastest SUV to cross 100,000 units in overseas sales
In a major product launch from Renault in five years, the company on Wednesday launched a next-generation Triber priced attractively between ₹6.2 lakh and ₹8.4 lakh
Hospitals have a steady quarter with occupancies rising 100 bps
Many see Tesla's India entry as an attempt to address the capacity glut at its global plants, from where excess inventory might be brought to India
Tesla opens bookings for Model Y in India at up to ₹67.89 lakh due to high import duties, with first deliveries expected later in 2025 from Shanghai plant
Downside risks from rare-earth magnets an overhang for the sector
Bengaluru-based Manipal Hospitals cements top spot with major expansion, aims IPO
IGI Therapeutics, a wholly owned subsidiary of Glenmark, has licensed its cancer and autoimmune drug ISB 2001 to AbbVie for an upfront payment of $700 million
Company says parts pipeline remains steady for now as orders placed in April are arriving; rare-earth supply disruption remains under close watch for future impact
India's pharma exports saw a significant rise in March, driven by fears of impending US tariffs. Industry experts anticipate impact of potential reciprocal tariffs on India's future export strategy
Apollo AyurVAID, one of India's largest Ayurvedic hospital chains, targets 1,000 beds and Rs 500 crore turnover by 2028, as demand for Ayurvedic treatments rises
While average selling prices rose 7.6% between 2019 and 2024 due to premiumisation and regulation costs, they are expected to rise more moderately at 4.5% CAGR till 2029
India's ultra-rich are embracing EVs, with the luxury electric segment growing 66% in 2025; Mercedes, BMW, Audi lead, aided by new launches and better charging infra
Torrent Pharma will acquire KKR's 46.39% stake in JB Pharma followed by open offer and merger, strengthening chronic segment and CDMO footprint in India and abroad
Torrent Pharma is negotiating to acquire JB Chemicals from KKR in a deal that may trigger an open offer, strengthening its position in the domestic pharma market
Company is 'comfortably placed' this year in sourcing critical supply, says automaker
EVs are taxed at 5% while hybrid vehicles attract an overall tax rate of 43%
Tata Motors plans to reintroduce its Ace diesel mini-truck without SCR tech to reduce total cost of ownership, while expanding rural presence with Intra range